Search research articles
Contact Us
Filters
Showing results (231-240 of 308) with videos related to
Page
of 31
Sort By:
Current Pharmaceutical Design
|
September 15, 2012
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer
Elena Galvani, Roberta Alfieri, Elisa Giovannetti, et al.
Journal of Thoracic Disease
|
March 7, 2018
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model
Luca Ampollini, Elisabetta Barocelli, Andrea Cavazzoni, et al.
Intensive Care Medicine
|
June 6, 2018
A global perspective on vasoactive agents in shock
Djillali Annane, Lamia Ouanes-Besbes, Daniel de Backer, et al.
Transplantation
|
November 18, 2022
Transcriptionally Distinct B Cells Infiltrate Allografts After Kidney Transplantation
Hengcheng Zhang, Cecilia B Cavazzoni, Benjamin L Hanson, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
April 6, 2017
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility
Andrea Ravelli, Giandomenico Roviello, Daniele Cretella, et al.
European Journal of Medicinal Chemistry
|
March 10, 2009
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line
Valentina Zuliani, Caterina Carmi, Mirko Rivara, et al.
BMC Health Services Research
|
January 19, 2017
COMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention study
Julie E Potter, Robert G Herkes, Lin Perry, et al.
Frontiers in Oncology
|
December 23, 2024
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Graziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Journal of Medicinal Chemistry
|
January 28, 2012
Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides
Caterina Carmi, Elena Galvani, Federica Vacondio, et al.
Biochemical Pharmacology
|
May 12, 2009
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
Silvia La Monica, Maricla Galetti, Roberta R Alfieri, et al.
Page
of 31
Search research articles
Search
Showing results (231-240 of 308) with videos related to
Sort By:
Page
of 31
Current Pharmaceutical Design
|
September 15, 2012
Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer
Elena Galvani, Roberta Alfieri, Elisa Giovannetti, et al.
Journal of Thoracic Disease
|
March 7, 2018
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model
Luca Ampollini, Elisabetta Barocelli, Andrea Cavazzoni, et al.
Intensive Care Medicine
|
June 6, 2018
A global perspective on vasoactive agents in shock
Djillali Annane, Lamia Ouanes-Besbes, Daniel de Backer, et al.
Transplantation
|
November 18, 2022
Transcriptionally Distinct B Cells Infiltrate Allografts After Kidney Transplantation
Hengcheng Zhang, Cecilia B Cavazzoni, Benjamin L Hanson, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
April 6, 2017
Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility
Andrea Ravelli, Giandomenico Roviello, Daniele Cretella, et al.
European Journal of Medicinal Chemistry
|
March 10, 2009
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line
Valentina Zuliani, Caterina Carmi, Mirko Rivara, et al.
BMC Health Services Research
|
January 19, 2017
COMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention study
Julie E Potter, Robert G Herkes, Lin Perry, et al.
Frontiers in Oncology
|
December 23, 2024
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
Graziana Digiacomo, Claudia Fumarola, Silvia La Monica, et al.
Journal of Medicinal Chemistry
|
January 28, 2012
Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides
Caterina Carmi, Elena Galvani, Federica Vacondio, et al.
Biochemical Pharmacology
|
May 12, 2009
Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
Silvia La Monica, Maricla Galetti, Roberta R Alfieri, et al.
Page
of 31